Vaccine Improves Brain Cancer Survival

Tuesday, 17 Sep 2013 02:56 PM

 

  Comment  |
   Contact  |
  Print  
|  A   A  
  Copy Shortlink
Biotechnology company Agenus Inc. said its experimental brain cancer vaccine increased the survival of patients without their cancer worsening in a mid-stage trial, compared with the standard treatment.

The vaccine, codenamed HSPPC-96, showed an almost 18 month median progression-free survival — a 160 percent increase versus current standard treatment of radiation combined with chemotherapy drug temozolomide.
 
The vaccine was being used in combination with the standard treatment to treat patients with newly diagnosed glioblastoma multiforme, an aggressive type of tumor which affects the brain.
 
Agenus plans to discuss a late-stage trial with the U.S. Food and Drug Administration, based on the trial data.
 
A preliminary analysis of the study in May had showed that the vaccine had a 146 percent increase in progression-free survival when compared with the standard-of-care.
 
"We are impressed by the data and look forward to feedback from the FDA regarding next steps," Roth Capital Partners analyst Joseph Pantginis wrote in a note.

© 2014 Thomson/Reuters. All rights reserved.

  Comment  |
   Contact  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

You Can Be Overweight and Perfectly Healthy: Researchers

Thursday, 27 Nov 2014 15:24 PM

Being fat is not the same as being unhealthy. While the conventional thinking has been that obesity is a medical problem . . .

Gluten-Free Thanksgiving Tips

Thursday, 27 Nov 2014 09:28 AM

Thanksgiving meals can pose a challenge for people who have to eat a gluten-free diet, an expert says.
Many traditi . . .

Liver Transplant Recipient Marks 25th Anniversary

Thursday, 27 Nov 2014 09:19 AM

Alyssa Riggan hasn't dwelled on being the first person in the U.S. to successfully receive part of a liver from a living . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved